
KemNet
KemNet is a YC Summer 2022 (S22) company. Based in Edmonton, AB, Canada; Remote. Team of 2.
About KemNet
Summary
KemNet supplies pharmacies with reformulated versions of established drugs optimized for specific patient populations. Its products use novel drug delivery formats to improve on standard formulations across categories including erectile dysfunction, hair growth, pain, weight loss, and women's health. KemNet replaces the work pharmacies would otherwise do to source or compound these specialty products independently.
Business model
A wholesale supply fee per reformulated drug product sold to pharmacies.
Go-to-market
Pharmacies are the direct customer, buying reformulated drug products through KemNet's B2B marketplace rather than sourcing them from traditional pharmaceutical distributors or compounding in-house.
From the Y Combinator listing
KemNet supplies reformulated drugs for specific groups of patients.
KemNet supplies pharmacies with premium reformulations of popular drugs that are more useful for specific groups of patients. For example, more than 30 pharmacies rely on KemNet to supply reformulated products for erectile dysfunction that work up to 8 times faster than alternatives. In addition to sexual function, products reformulated for novel drug delivery and supplied on KemNet include medications for hair growth, pain, weight loss and women's health.
Facts
- Healthcare / Healthcare -> Healthcare IT
- Edmonton, AB, Canada; Remote
- 2
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works